Carl Schoellhammer

Partner at DeciBio

Speaker

Carl leads DeciBio’s Advanced Therapies practice, bringing experience across biopharma, manufacturing and bioprocessing, and supply chain strategy. He has advised clients on projects spanning pipeline prioritization and lifecycle management, forecasting, indication roadmapping, growth strategy, and M&A across biopharma, life science tools, and cell and gene therapies. Prior to joining DeciBio, Carl founded and served as CEO of Suono Bio, a biotechnology company spun out of his Ph.D. research at MIT. Carl holds a B.S. from the University of California, Berkeley, and a Ph.D. from MIT, where he trained with Professor Robert Langer.